The InnoMedCatalyst I3 project invites healthcare providers to express their interest in participating as real-world test beds for the validation and demonstration of innovative solutions in predictive, preventive, personalised, participatory and precision medicine (5P Medicine).

Beyond serving as test environments, participating organisations will play a central role in identifying unmet clinical or operational needs within their institutions. These needs will form the basis for targeted matchmaking with innovators capable of developing or adapting solutions to address them.

Through this needs-driven approach, selected healthcare providers will be matched with high-potential innovators to co-develop and validate solutions tailored to real-world challenges. This ensures that innovation activities are directly aligned with healthcare priorities and have a higher potential for adoption and impact.

In addition, each healthcare provider–innovator pair will receive dedicated one-to-one mentoring support (up to 20 hours) from the InnoMedCatalyst consortium. This tailored support will guide partners through the co-creation of a competitive project proposal for submission to upcoming funding opportunities, including future I3 calls and relevant Horizon Europe programmes.

This integrated pathway—needs identification, matchmaking, real-world testing and proposal development—is designed to accelerate innovation uptake while significantly increasing the likelihood of securing follow-up funding.



Why Participate?

• Get matched with innovative solution providers

• Receive up to 20 hours of tailored mentoring and coaching

• Co-develop a strong proposal for I3 or Horizon Europe

• Increase your chances of securing EU funding

• Position your organisation at the forefront of 5P Medicine



By participating, healthcare providers will not only contribute to advancing 5P Medicine but also actively shape innovation pipelines based on their real needs, while positioning themselves for future funding and long-term collaboration.

The InnoMedCatalyst Open Call will select up to 15 innovative ideas/ projects/ needs to participate. No direct financial support is provided under this Open Call.



Who we are:

The InnoMedCatalyst project is a European initiative aimed at enhancing the regional innovation capacity of precision and personalized medicine ecosystems. It focuses on enabling start-ups, spinoffs, scaleups and healthcare providers to develop, test and refine digital health solutions as investment-ready business cases. The project aims to catalyze innovation and bridge the gap between MedTech companies and Healthcare providers, creating a sustainable entrepreneurial empowerment program that offers mentorship to advance the most promising digital technologies identified in partner countries. By 2026, the project aims to generate at least 20 investment-ready projects in precision medicine, with a strong focus on the regional level and involving several partners.



Guidelines for Applicants (Healthcare Providers)

1. Eligibility

Healthcare providers eligible to apply include:

• Hospitals (public or private)

• Clinical centres and specialised units

• Diagnostic and research laboratories

• Integrated care providers

• Organisations serving specific populations (e.g. aged care centres, community health services, migrant centres)



2. Areas of Interest

Applicants should indicate their capacity and interest in one or more of the following:

• Genomics and biomarker-based diagnostics

• Digital health and AI applications

• Clinical decision support systems

• Personalised therapies and treatment pathways

• Data integration and interoperability



3. What We Ask from Healthcare Providers

Submit a clearly defined unmet need or challenge (clinical, operational, or technological)

Engage in matchmaking and co-creation activities with selected innovators

Provide access to relevant environments for testing and validation

Participate in mentoring sessions and proposal development

Contribute feedback and evaluation data during pilot activities



4. Selection Criteria

Applications will be assessed based on:

• Relevance to 5P Medicine priorities

• Capacity to host and support pilot activities

• Commitment to collaboration and innovation uptake

• Diversity and representativeness of patient populations

• Potential for impact and scalability



APPLY NOW through the Life Science Open Space Platform https://www.lifescienceopenspace.com/

Applications close May 15th 2026.

For any questions, contact us directly via innomedcatalyst@medicnest.eu.